What Do We Know About Clodronate Now? A Medical and Veterinary Perspective.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Review
Summary
This research article delves into the controversy surrounding the use of bisphosphonates in horses, examining different classes of the drug and their varying effects originating from studies in human and veterinary medicine. The collaborative review details the latest applications, safety measures, and potential future uses of bisphosphonates in both human and equine treatment.
Overview of Bisphosphonates
As per the article, bisphosphonates are a class of drugs typically used to treat osteoporosis and other bone diseases in humans. In veterinary medicine, particularly in equines, these drugs have also been used for treating bone-related disorders. However, the appropriateness and safety of using bisphosphonates in horses have recently come under controversy due to the potential side effects and unfamiliarity with the mechanism of action.
Different Classes of Bisphosphonates
- The study describes how bisphosphonates can be categorized into different classes based on their chemical structure and mechanism of action. The classes include non-nitrogen-containing bisphosphonates and nitrogen-containing bisphosphonates.
- Differences between these classes not only pertain to the structure but also to the distinct mechanisms of actions and effects they exert, which can lead to varied outcomes for human and animal patients.
Interdisciplinary Collaboration
- A unique attribute of the paper is that it’s a collaborative effort between veterinary surgeons and medical doctors. This cross-sectional collaboration helps draw parallels between the use of bisphosphonates in human and veterinary medicine.
- By pooling knowledge from both fields, the authors aim to provide a more comprehensive understanding of the implications of using bisphosphonates and consider future uses for the drug.
Safety Aspects and Future Potential of Bisphosphonates
- The report discusses the safety aspects of bisphosphonates in both humans and horses. It brings forth the adverse effects, contraindications, and the importance of correct dosage, highlighting the need for careful analysis before treatment.
- Alongside the current use, the authors also explore potential future uses of bisphosphonates, considering their efficacy and safety factors in treatments other than bone disorders.
Cite This Article
Publication
Researcher Affiliations
- Ranch & Coast Equine Practice, Inc, Bonsall, CA; IlluminX Consulting Inc, Bonsall, CA.
- Istituti Clinici Scientifici Maugeri IRCCS, Rheumatology and Rehabilitation Unit of the Institute of Castel Goffredo, Mantua, Italy.
- Dechra Veterinary Products EU, Shrewsbury, UK. Electronic address: lizzie.barker@dechra.com.
- Dechra Veterinary Products US, Overland Park, KS.
- Dechra Veterinary Products EU, 's-Hertogenbosch, Netherlands.
MeSH Terms
- Animals
- Clodronic Acid / therapeutic use
- Diphosphonates / adverse effects
- Horses
Citations
This article has been cited 3 times.- Szalai Z, Bednárik J, Tóth BS, Takács A, Tekula S, Kőhidai L, Karaghiosoff K, Drahos L, Keglevich G. Cytotoxic Activity of Bisphosphonic Derivatives Obtained by the Michaelis-Arbuzov or the Pudovik Reaction. Pharmaceuticals (Basel) 2025 Jan 13;18(1).
- Mass E. The stunning clodronate. J Exp Med 2023 Jun 5;220(6).
- Vergara-Hernandez FB, Nielsen BD, Colbath AC. Is the Use of Bisphosphonates Putting Horses at Risk? An Osteoclast Perspective. Animals (Basel) 2022 Jul 3;12(13).